Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02921243 · ClinicalTrials.gov registry record
Schizophrenia and the Gut Microbiome
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 11
- Enrollment target
NCT02921243 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 11 participants.
The verdict
NCT02921243 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
In a sample of 20 inpatients with a DSM-IV-TR/DSM 5 diagnosis of schizophrenia or schizoaffective disorder, investigators propose to conduct a prospective, 2 week observational trial to collect gastrointestinal stool samples in order to characterize the microbiota in people with schizophrenia and examine its variability over time. Participants may elect to participate for an additional two weeks, during which they will receive the prebiotic, oligofructose-enriched inulin (FOS), in order to examine its effects on the relative preponderance of butyrate-producing bacteria in the gut microbiome. Investigators will use an inpatient sample in order to standardize meals, exercise and environmental mediators. This is considered a feasibility, pilot study in order to apply for future grant funding. Investigators will recruit patients from the Treatment Research Program inpatient unit, Maryland Psychiatric Research Center, University of Maryland School of Medicine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2019-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02921243
The ClinicalTrials.gov registry entry for NCT02921243 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02921243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02921243 about?
NCT02921243 is a clinical study titled "Schizophrenia and the Gut Microbiome". In a sample of 20 inpatients with a DSM-IV-TR/DSM 5 diagnosis of schizophrenia or schizoaffective disorder, investigators propose to conduct a prospective, 2 week observational trial to collect gastrointestinal stool samples in order to characterize the microbiota in people with schizophrenia and ex...
What is the current status of trial NCT02921243?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2016-10-01. Estimated completion is 2019-06-18.
Who is sponsoring clinical trial NCT02921243?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.